UK markets open in 2 hours 53 minutes

AbbVie Inc. (0QCV.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
146.95-0.42 (-0.28%)
At close: 06:14PM GMT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 3N/A
S&P500 52-week change 328.64%
52-week high 3147.40
52-week low 3146.93
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.5B
Implied shares outstanding 6N/A
Float 81.76B
% held by insiders 10.14%
% held by institutions 172.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 35.99
Trailing annual dividend yield 34.06%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 8.95%
Operating margin (ttm)31.81%

Management effectiveness

Return on assets (ttm)8.07%
Return on equity (ttm)35.20%

Income statement

Revenue (ttm)54.32B
Revenue per share (ttm)30.72
Quarterly revenue growth (yoy)-5.40%
Gross profit (ttm)N/A
EBITDA 26.36B
Net income avi to common (ttm)4.82B
Diluted EPS (ttm)6.97
Quarterly earnings growth (yoy)-66.80%

Balance sheet

Total cash (mrq)12.82B
Total cash per share (mrq)7.26
Total debt (mrq)60.58B
Total debt/equity (mrq)582.66%
Current ratio (mrq)0.87
Book value per share (mrq)5.87

Cash flow statement

Operating cash flow (ttm)22.84B
Levered free cash flow (ttm)22.63B